2U3:FRA
Alcon AG
56,52 €
arrow_upward
+0,75%(+0,42) 1D
8 қаз., 08:03:08 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2U3...
Open
56,52 €
High
56,52 €
Low
56,52 €
Mkt. cap
26,25 млрд
Avg. vol.
137,00
Volume
0,00
52-wk high
73,96 €
52-wk low
51,78 €
No. of employees
25 мың
Open
56,52 €
High
56,52 €
Low
56,52 €
Mkt. cap
26,25 млрд
Avg. vol.
137,00
Volume
0,00
52-wk high
73,96 €
52-wk low
51,78 €
No. of employees
25 мың
News stories
From web sources and news partners
AD HOC NEWS
·
19 сағат бұрын
Alcon stock trades at CHF 52.90 before November 10 earnings
AD HOC NEWS
·
1 күн бұрын
Alcon stock after-hours at EUR 56.24: minus 1.88 percent versus the Lang & Schwarz prior close
AD HOC NEWS
·
2 күн бұрын
Jefferies keeps Buy rating on Alcon stock at USD 85 target
AD HOC NEWS
·
2 күн бұрын
Alcon stock after-hours at EUR 57.18: plus 1.08 percent versus prior close
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25 мың
Founded1945
HeadquartersЖенева, Женева, Швейцария
SectorMedical device
Websitealcon.com